Urinary Tract Infections (UTI) are the most common bacterial infection among Long Term Care residents and is the second most common infection diagnosed in the acute hospital setting, accounting for almost 5% of all emergency department visits by adults aged 65 years and older in the United States each year. Current culture methods are limited by their sensitivity, as well as ability to identify polymicrobial infection.
Empirical treatment of a UTI occurs in many patient populations, however, this practice has contributed to the antibiotic resistance trend occurring globally. Patients are treated with a course of antibiotics which may not be the optimal choice based on pathogens present.
Promus Diagnostics proprietary molecular UTI assay includes 24 pathogens (gram positive, gram negative and fungi), coupled with three key antibiotic resistance markers in the same test and from the same sample. Our comprehensive test provides clinicians with a reliable and clear picture of the causative pathogens in asymptomatic patients.